AIP
ORGS

Ameritas Investment Partners’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Ameritas Investment Partners’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-160
Closed -$9K – 3260
2021
Q1 		$9K Hold
160
– – ﹤0.01% 2908
2020
Q4 		$7K Hold
160
– – ﹤0.01% 2924
2020
Q3 		$8K Hold
160
– – ﹤0.01% 2834
2020
Q2 		$10K Buy
+160
New +$9.68K ﹤0.01% 2740

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ameritas Investment Partners's ORGS Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 160 shares — an estimated $9K sold.

Ameritas Investment Partners first reported a position in ORGS in Q2 2020 and held it in 4 quarters. The position peaked at $10K in Q2 2020. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 160 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $9K.
  • Ameritas Investment Partners first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Ameritas Investment Partners's Orgenesis Inc. Common Stock position peaked at $10K in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.